Skip to main content
. 2023 Sep 19;24(18):14256. doi: 10.3390/ijms241814256

Figure 4.

Figure 4

The role of GBM heterogeneity in GBM recurrence. In addition to patient variability, the cells within the tumor may belong to different subpopulations and carry a variety of active molecular processes. An untargeted process in cell (A) may trigger survival molecular mechanisms in cell (B) via soluble factors, resulting in the emergence of a new resistant subpopulation and tumor progression. Cell (C) represents another innately resistant subpopulation.